CT尿路造影诊断膀胱癌:检查特征及假阳性和假阴性结果的原因分析
回顾性分析1623例CT尿路造影中710例因血尿或膀胱癌病史并在6个月内行膀胱镜检查的病例,检出95例膀胱癌,CT尿路造影准确率91.5%、敏感度86.3%、特异度92.4%、阳性预测值63.6%、阴性预测值97.8%;假阳性主要原因为良性前列腺增生、膀胱小梁化和治疗改变,假阴性主要原因为技术因素。
要点
- CT尿路造影诊断膀胱癌准确率91.5%,敏感度86.3%,特异度92.4%,阴性预测值97.8%。
- 假阳性最常见原因为良性前列腺增生(12例)、膀胱小梁化(9例)和治疗改变(8例)。
- 13例假阴性中11例由技术因素导致,无感知错误。
核心结论
- CT尿路造影是诊断膀胱癌的准确检查方法,但在主要依赖排泄期图像的方案中,总体敏感度仍不足以替代膀胱镜检查。
- 认识膀胱癌的类似病变可能减少假阳性结果,改进CT尿路造影技术可能减少假阴性结果。
研究设计与样本
- 回顾性研究,经IRB批准并符合HIPAA要求,分析2010年10月至2013年12月31日间1623例CT尿路造影报告。
- 纳入710例因血尿或膀胱癌病史且在6个月内行膀胱镜检查的病例,参考标准为手术病理或至少1年临床随访。
关键影像表现/征象
- 假阳性43例中,解释错误主要归因于良性前列腺增生(12例)、膀胱小梁化(9例)和治疗改变(8例)。
- 其他假阳性原因包括血凝块、正常解剖误判、感染/炎症改变或无膀胱镜对应发现。
- 假阴性13例中,11例由技术因素导致,1例由大量尿液残留导致,1例由伪影导致。
- 无感知错误。
诊断标准与关键数值
- CT尿路造影诊断膀胱癌的准确率为91.5%(650/710)。
- 敏感度为86.3%(82/95),特异度为92.4%(568/615)。
- 阳性预测值为63.6%(82/129),阴性预测值为97.8%(568/581)。
临床应用与阅片要点
- 在主要依赖排泄期图像的CT尿路造影方案中,敏感度不足以替代膀胱镜检查。
- 认识良性前列腺增生、膀胱小梁化和治疗改变等膀胱癌类似病变可能减少假阳性结果。
- 改进CT尿路造影技术可能减少假阴性结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine test characteristics of CT urography for detecting bladder cancer in patients with hematuria and those undergoing surveillance, and to analyze reasons for false-positive and false-negative results.
METHODS: A HIPAA-compliant, IRB-approved retrospective review of reports from 1623 CT urograms between 10/2010 and 12/31/2013 was performed. 710 examinations for hematuria or bladder cancer history were compared to cystoscopy performed within 6 months. Reference standard was surgical pathology or 1-year minimum clinical follow-up. False-positive and false-negative examinations were reviewed to determine reasons for errors.
RESULTS: Ninety-five bladder cancers were detected. CT urography accuracy: was 91.5% (650/710), sensitivity 86.3% (82/95), specificity 92.4% (568/615), positive predictive value 63.6% (82/129), and negative predictive value was 97.8% (568/581). Of 43 false positives, the majority of interpretation errors were due to benign prostatic hyperplasia (n = 12), trabeculated bladder (n = 9), and treatment changes (n = 8). Other causes include blood clots, mistaken normal anatomy, infectious/inflammatory changes, or had no cystoscopic correlate. Of 13 false negatives, 11 were due to technique, one to a large urinary residual, one to artifact. There were no errors in perception.
CONCLUSION: CT urography is an accurate test for diagnosing bladder cancer; however, in protocols relying predominantly on excretory phase images, overall sensitivity remains insufficient to obviate cystoscopy. Awareness of bladder cancer mimics may reduce false-positive results. Improvements in CTU technique may reduce false-negative results.
引用
- Trinh TW, Glazer DI, Sadow CA, et al. Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results. Abdom Radiol (NY). 2018. PMID: 28677000. doi:10.1007/s00261-017-1249-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。